MUMBAI, January 16, 2018 /PRNewswire/ --
The Government of Maharashtra and Johnson & Johnson India will work together ondesigning new programs and strengthening existing programs to help address public health issues in following areas:
- Mission TB Free Maharashtra through public awareness and skill development of doctors;
- Prevention of Hospital Acquired
Johnson & Johnson Private Limited today announced a strategic partnership with the Government of Maharashtra to implement focused disease interventions that have the potential to significantly improve the health of people and strengthen health care in the state. A Memorandum of Understanding (MoU) for the partnership was signed today in the presence of the Honorable Minister of Public Health and Family Welfare, Government of Maharashtra, Shri Dr. Deepak Sawant at Mantralaya, Mumbai.
Commenting on the development, Honorable Minister of Public Health and Family Welfare, Shri Dr. Deepak Sawant said, "Johnson & Johnson India will help the state government in raising awareness amongst mine workers and their families in the state, who are at an increased risk of tuberculosis. Nine districts in Maharashtra face the maximum rate of infant mortality. In these districts, Johnson & Johnson India will organize skill development programmes for nurses, along with other activities to train them for providing proper care to infants and their treatment during the Golden-Minute. Apart from these initiatives, a collaborative awareness campaign would also be undertaken to educate people about the various infectious diseases during pregnancy."
Through this collaboration, the Government of Maharashtra and Johnson & Johnson India will work together to address pressing public health issues such as tuberculosis (TB), maternal and child health, infection prevention, diabetes, obesity and menstrual hygiene and will support healthcare professionals and nurses in the state to further develop their skills in these areas. Below is a summary of the different healthcare interventions that the State Government and Johnson & Johnson India will jointly work upon:
Speaking about the partnership, Mr. Sushobhan Dasgupta, Managing Director, Johnson & Johnson Medical India & Vice President, Johnson & Johnson Orthopaedics Asia-Pacific said, "At Johnson & Johnson India, we share a common goal with the Government of Maharashtra to see that people have access to quality healthcare. This partnership will help us achieve our objectives towards improving the public health outcomes of the state through highly focused initiatives."
Johnson & Johnson India will provide strategic and technical advisory support and oversee the successful execution of all these programmes.
Johnson & Johnson spread its root into India 70 years ago. Since then, the Company has played a role in helping millions of people in India be well and stay well through our array of cutting-edge healthcare offerings. This partnership with the Government of Maharashtra focuses on five key areas where Johnson & Johnson can optimize its diverse expertise, capabilities, collaborations and resources to make scalable and sustainable impact in promotion and advancement of the healthier society.
About Johnson & Johnson India
Caring for the world, one person at a time, inspires and unites the people of Johnson & Johnson. We embrace innovation-bringing ideas, products and services to life to advance the health and well-being of people around the world. We believe in collaboration, and that has led to breakthrough after breakthrough, from medical miracles that have changed lives, to the simple consumer products that make every day a little better.
Media Contact :
Joshina Kapoor Johnson & Johnson India Phone: +91-9820711080 Email: firstname.lastname@example.org
Preeti Binoy Johnson & Johnson India Phone: +91-9769137505 Email: email@example.com Neeti Sharma SPAG Asia firstname.lastname@example.org +91-9819958140
Subscribe to our Free Newsletters!
Birth Control Implant is a long-acting birth control contraceptive inserted into the arm. It is a ...
Mastocytosis is a rare condition marked by accumulation of mast cells under the skin and various ...
Lusutrombopag is used to treat abnormally low platelet counts (thrombocytopenia) in adult patients ...View All